Unselective use of intranasal mupirocin ointment for controlling propagation of methicillin-resistant Staphylococcus aureus in a thoracic surgery ward
References (11)
The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience
J Hosp Infect
(1994)- et al.
Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment
J Hosp Infect
(2000) - et al.
Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolate from a community hospital in Japan
J Hosp Infect
(2001) - et al.
Guideline for prevention of surgical site infection, 1999
Am J Infect Control
(1999) Staphylococcus aureus infections
N Engl J Med
(1998)
There are more references available in the full text version of this article.
Cited by (9)
Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities
2021, Journal of Hospital InfectionCitation Excerpt :This study had a small sample size; thus, it was likely to be underpowered and at risk of type I error. Further evidence was obtained from thirteen UBA studies, [119,121–124,126,130–132,134,143–146] which found similar results. Introduction of mupirocin itself was beneficial in one study [144] and not significantly reduced in another. [145]
Infection control for a methicillin-resistant Staphylococcus aureus outbreak in an advanced emergency medical service center, as monitored by molecular analysis
2013, Journal of Infection and ChemotherapyInvestigation of methicillin resistant Staphylococcus aureus in neonatal intensive care unit
2014, International Journal of Clinical and Experimental Medicine
Copyright © 2005 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.